Evan Tobin

Suggest Changes
Learn More
PURPOSE Monoclonal antibodies (mAb) in combination and mAbs combined with a radionuclide (radioimmunotherapy) have both been more effective in patients than mAb monotherapy. EXPERIMENTAL DESIGN(More)
  • 1